RenovoRx Stock Based Compensation vs Free Cash Flow Analysis

Stocks . USA . 
Stock . RenovoRx
RNXT Stock  USD 1.26  0.10  7.35%   
RenovoRx financial indicator trend analysis is much more than just breaking down RenovoRx prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether RenovoRx is a good investment. Please check the relationship between RenovoRx Stock Based Compensation and its Free Cash Flow accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RenovoRx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
For more information on how to buy RenovoRx Stock please use our How to Invest in RenovoRx guide.

Stock Based Compensation vs Free Cash Flow

Stock Based Compensation vs Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of RenovoRx Stock Based Compensation account and Free Cash Flow. At this time, the significance of the direction appears to have pay attention.
The correlation between RenovoRx's Stock Based Compensation and Free Cash Flow is -0.97. Overlapping area represents the amount of variation of Stock Based Compensation that can explain the historical movement of Free Cash Flow in the same time period over historical financial statements of RenovoRx, assuming nothing else is changed. The correlation between historical values of RenovoRx's Stock Based Compensation and Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Stock Based Compensation of RenovoRx are associated (or correlated) with its Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow has no effect on the direction of Stock Based Compensation i.e., RenovoRx's Stock Based Compensation and Free Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.97
Relationship DirectionNegative 
Relationship StrengthSignificant

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
Most indicators from RenovoRx's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into RenovoRx current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RenovoRx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
For more information on how to buy RenovoRx Stock please use our How to Invest in RenovoRx guide.At this time, RenovoRx's Issuance Of Capital Stock is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 44.5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 3.5 M in 2024.
 2021 2023 2024 (projected)
Depreciation And Amortization9K5.4K5.1K
Interest Income57K111K64.4K

RenovoRx fundamental ratios Correlations

Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Net Tangible Assets
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Other Assets
Cash And Short Term Investments
Common Stock Total Equity
Common Stock Shares Outstanding
Non Current Liabilities Total
Other Current Assets
Other Stockholder Equity
Total Liab
Net Invested Capital
Total Current Assets
Capital Stock
Net Working Capital
Common Stock
Current Deferred Revenue
Total Assets
-0.420.02-0.080.880.62-0.78-0.150.071.0-0.2-0.02-0.581.00.2-0.03-0.650.870.58-0.670.881.00.20.980.20.2
Short Long Term Debt Total
-0.42-0.8-0.53-0.66-0.80.90.840.39-0.41-0.57-0.720.85-0.410.54-0.690.83-0.7-0.840.73-0.71-0.420.54-0.30.540.54
Other Current Liab
0.02-0.80.920.130.28-0.53-0.51-0.830.010.370.43-0.380.01-0.360.4-0.340.220.36-0.180.210.02-0.36-0.17-0.36-0.36
Total Current Liabilities
-0.08-0.530.92-0.15-0.09-0.27-0.13-0.98-0.080.060.05-0.01-0.08-0.070.050.01-0.050.00.18-0.06-0.08-0.07-0.29-0.07-0.07
Total Stockholder Equity
0.88-0.660.13-0.150.91-0.91-0.580.220.870.210.45-0.890.87-0.20.4-0.930.980.88-0.941.00.88-0.20.88-0.2-0.2
Net Tangible Assets
0.62-0.80.28-0.090.91-0.88-0.850.220.60.590.75-0.990.6-0.570.75-0.980.880.97-0.970.90.62-0.570.62-0.57-0.57
Net Debt
-0.780.9-0.53-0.27-0.91-0.880.680.18-0.76-0.33-0.530.9-0.760.31-0.50.92-0.92-0.890.86-0.94-0.780.31-0.690.310.31
Retained Earnings
-0.150.84-0.51-0.13-0.58-0.850.68-0.05-0.13-0.85-0.960.89-0.130.8-0.950.83-0.57-0.880.79-0.59-0.150.8-0.120.80.8
Accounts Payable
0.070.39-0.83-0.980.220.220.18-0.050.070.10.12-0.140.07-0.060.13-0.140.110.15-0.30.130.07-0.060.28-0.06-0.06
Cash
1.0-0.410.01-0.080.870.6-0.76-0.130.07-0.22-0.05-0.551.00.21-0.05-0.640.860.56-0.650.871.00.210.980.210.21
Non Current Assets Total
-0.2-0.570.370.060.210.59-0.33-0.850.1-0.220.82-0.58-0.22-0.950.96-0.480.180.56-0.450.21-0.2-0.95-0.2-0.95-0.95
Non Currrent Assets Other
-0.02-0.720.430.050.450.75-0.53-0.960.12-0.050.82-0.8-0.05-0.790.91-0.740.450.78-0.710.45-0.02-0.79-0.03-0.79-0.79
Other Assets
-0.580.85-0.38-0.01-0.89-0.990.90.89-0.14-0.55-0.58-0.8-0.550.55-0.750.99-0.87-0.990.97-0.89-0.580.55-0.560.550.55
Cash And Short Term Investments
1.0-0.410.01-0.080.870.6-0.76-0.130.071.0-0.22-0.05-0.550.21-0.05-0.640.860.56-0.650.871.00.210.980.210.21
Common Stock Total Equity
0.20.54-0.36-0.07-0.2-0.570.310.8-0.060.21-0.95-0.790.550.21-0.880.44-0.22-0.480.41-0.20.21.00.191.01.0
Common Stock Shares Outstanding
-0.03-0.690.40.050.40.75-0.5-0.950.13-0.050.960.91-0.75-0.05-0.88-0.670.360.75-0.640.4-0.03-0.88-0.03-0.88-0.88
Non Current Liabilities Total
-0.650.83-0.340.01-0.93-0.980.920.83-0.14-0.64-0.48-0.740.99-0.640.44-0.67-0.91-0.990.99-0.93-0.660.44-0.630.440.44
Other Current Assets
0.87-0.70.22-0.050.980.88-0.92-0.570.110.860.180.45-0.870.86-0.220.36-0.910.85-0.910.990.87-0.220.85-0.22-0.22
Other Stockholder Equity
0.58-0.840.360.00.880.97-0.89-0.880.150.560.560.78-0.990.56-0.480.75-0.990.85-0.970.880.58-0.480.56-0.48-0.48
Total Liab
-0.670.73-0.180.18-0.94-0.970.860.79-0.3-0.65-0.45-0.710.97-0.650.41-0.640.99-0.91-0.97-0.93-0.670.41-0.680.410.41
Net Invested Capital
0.88-0.710.21-0.061.00.9-0.94-0.590.130.870.210.45-0.890.87-0.20.4-0.930.990.88-0.930.88-0.20.86-0.2-0.2
Total Current Assets
1.0-0.420.02-0.080.880.62-0.78-0.150.071.0-0.2-0.02-0.581.00.2-0.03-0.660.870.58-0.670.880.20.980.20.2
Capital Stock
0.20.54-0.36-0.07-0.2-0.570.310.8-0.060.21-0.95-0.790.550.211.0-0.880.44-0.22-0.480.41-0.20.20.191.01.0
Net Working Capital
0.98-0.3-0.17-0.290.880.62-0.69-0.120.280.98-0.2-0.03-0.560.980.19-0.03-0.630.850.56-0.680.860.980.190.190.19
Common Stock
0.20.54-0.36-0.07-0.2-0.570.310.8-0.060.21-0.95-0.790.550.211.0-0.880.44-0.22-0.480.41-0.20.21.00.191.0
Current Deferred Revenue
0.20.54-0.36-0.07-0.2-0.570.310.8-0.060.21-0.95-0.790.550.211.0-0.880.44-0.22-0.480.41-0.20.21.00.191.0
Click cells to compare fundamentals

RenovoRx Account Relationship Matchups

High Positive Relationship

Cash
+ 1.0
Total Assets
Cash And Short Term Investments
+ 1.0
Total Assets
Total Current Assets
+ 1.0
Total Assets
Net Invested Capital
+ 1.0
Total Stockholder Equity
Cash And Short Term Investments
+ 1.0
Cash
Total Current Assets
+ 1.0
Cash

High Negative Relationship

Other Stockholder Equity
- 0.99
Non Current Liabilities Total
Other Stockholder Equity
- 0.99
Other Assets
Other Assets
- 0.99
Net Tangible Assets
Non Current Liabilities Total
- 0.98
Net Tangible Assets
Accounts Payable
- 0.98
Total Current Liabilities
Total Liab
- 0.97
Other Stockholder Equity

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for RenovoRx Stock Analysis

When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY